{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:52:15Z","timestamp":1789055535503,"version":"build-2803163510"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T00:00:00Z","timestamp":1394409600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0091408","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T16:47:31Z","timestamp":1394470051000},"page":"e91408","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Behavioral and Histopathological Assessment of Adult Ischemic Rat Brains after Intracerebral Transplantation of NSI-566RSC Cell Lines"],"prefix":"10.1371","volume":"9","author":[{"given":"Naoki","family":"Tajiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken L.","family":"Hayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Hazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Johe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar V.","family":"Borlongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12975-012-0241-2","article-title":"In vivo animal stroke models: a rationale for rodent and non-human primate models","volume":"4","author":"N Tajiri","year":"2013","journal-title":"Transl Stroke Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/1871527311312030013","article-title":"The battle of the sexes for stroke therapy: female- versus male-derived stem cells","volume":"12","author":"Y Kaneko","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.2174\/138161212802002733","article-title":"Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells","volume":"18","author":"Y Kaneko","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pneurobio.2011.08.005","article-title":"The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders","volume":"95","author":"CV Borlongan","year":"2011","journal-title":"Prog Neurobiol"},{"key":"ref5","first-page":"1674","article-title":"Bone marrow stem cell mobilization in stroke: a \u2018bonehead\u2019 may be good after all! Leukemia","volume":"25","author":"CV Borlongan","year":"2011"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1161\/STROKEAHA.113.001295","article-title":"Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center","volume":"44","author":"SP Tan Tanny","year":"2013","journal-title":"Stroke"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1001\/jama.2013.6959","article-title":"Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke","volume":"309","author":"JL Saver","year":"2013","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.23744","article-title":"Advanced imaging to extend the therapeutic time window of acute ischemic stroke","volume":"73","author":"M Fisher","year":"2013","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3727\/096368909X470883","article-title":"Who\u2019s in favor of translational cell therapy for stroke: STEPS forward please?","volume":"18","author":"M Chopp","year":"2009","journal-title":"Cell Transplant"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/STROKEAHA.108.526863","article-title":"Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke","volume":"40","author":"P Stem Cell Therapies as an Emerging Paradigm in Stroke","year":"2009","journal-title":"Stroke"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1586\/14737175.8.8.1193","article-title":"Cell-based therapy in ischemic stroke","volume":"8","author":"DC Hess","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2184.2008.00486.x","article-title":"Stem cells and neurological diseases","volume":"41","author":"DC Hess","year":"2008","journal-title":"Cell Prolif"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2217\/17460751.3.3.249","article-title":"Potential of stem\/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic","volume":"3","author":"CV Borlongan","year":"2008","journal-title":"Regen Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/B978-0-444-59544-7.00006-8","article-title":"Advantages and challenges of alternative sources of adult-derived stem cells for brain repair in stroke","volume":"201","author":"PR Sanberg","year":"2012","journal-title":"Prog Brain Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/bmb\/lds001","article-title":"Neurological disorders and the potential role for stem cells as a therapy","volume":"101","author":"PR Sanberg","year":"2012","journal-title":"Br Med Bull"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neubiorev.2011.05.010","article-title":"Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke","volume":"36","author":"MC Rodrigues","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/exnr.1997.6730","article-title":"Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats","volume":"149","author":"CV Borlongan","year":"1998","journal-title":"Exp Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9440(10)62546-1","article-title":"Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation","volume":"160","author":"PT Nelson","year":"2002","journal-title":"Am J Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1545968309335978","article-title":"The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion","volume":"23","author":"P Stroemer","year":"2009","journal-title":"Neurorehabil Neural Repair"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/B978-0-444-59544-7.00007-X","article-title":"Prospects for stem cell-derived therapy in stroke","volume":"201","author":"JD Sinden","year":"2012","journal-title":"Prog Brain Res"},{"key":"ref21","first-page":"165ra164","article-title":"Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis","volume":"4","author":"YD Teng","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2174\/157015911798376299","article-title":"Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research","volume":"9","author":"YD Teng","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neulet.2011.03.017","article-title":"Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats","volume":"494","author":"L Xu","year":"2011","journal-title":"Neurosci Lett"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.tp.0000235532.00920.7a","article-title":"Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats","volume":"82","author":"L Xu","year":"2006","journal-title":"Transplantation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cne.22022","article-title":"Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry","volume":"514","author":"L Xu","year":"2009","journal-title":"J Comp Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e42614","DOI":"10.1371\/journal.pone.0042614","article-title":"Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation","volume":"7","author":"MP Hefferan","year":"2012","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/scrt209","article-title":"Amelioration of motor\/sensory dysfunction and spasticity in a rat model of acute lumbar spinal cord injury by human neural stem cell transplantation","volume":"4","author":"S van Gorp","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuroscience.2007.02.065","article-title":"Functional recovery in rats with ischemic paraplegia after spinal grafting of human spinal stem cells","volume":"147","author":"D Cizkova","year":"2007","journal-title":"Neuroscience"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.1097\/BRS.0b013e3181d77a47","article-title":"Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs","volume":"36","author":"B Raore","year":"2011","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3727\/096368910X503406","article-title":"Analysis of dosing regimen and reproducibility of intraspinal grafting of human spinal stem cells in immunosuppressed minipigs","volume":"19","author":"D Usvald","year":"2010","journal-title":"Cell Transplant"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pmed.0040039","article-title":"Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord","volume":"4","author":"J Yan","year":"2007","journal-title":"PLoS Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1089\/scd.2010.0003","article-title":"The pleotrophic effects of insulin-like growth factor-I on human spinal cord neural progenitor cells","volume":"19","author":"JS Lunn","year":"2010","journal-title":"Stem Cells Dev"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/term.223","article-title":"Characterization of a human fetal spinal cord stem cell line, NSI-566RSC, and its induction to functional motoneurons","volume":"4","author":"X Guo","year":"2010","journal-title":"J Tissue Eng Regen Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1634\/stemcells.2005-0518","article-title":"Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice","volume":"24","author":"J Yan","year":"2006","journal-title":"Stem Cells"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/stem.1079","article-title":"Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients","volume":"30","author":"JD Glass","year":"2012","journal-title":"Stem Cells"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e63553","DOI":"10.1371\/journal.pone.0063553","article-title":"Blood-brain barrier alterations provide evidence of subacute diaschisis in an ischemic stroke rat model","volume":"8","author":"S Garbuzova-Davis","year":"2013","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e43779","DOI":"10.1371\/journal.pone.0043779","article-title":"Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats","volume":"7","author":"N Tajiri","year":"2012","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/scd.2009.0340","article-title":"Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke","volume":"19","author":"CV Borlongan","year":"2010","journal-title":"Stem Cells Dev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2202-10-126","article-title":"Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke","volume":"10","author":"N Matsukawa","year":"2009","journal-title":"BMC Neurosci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1741-7007-7-31","article-title":"Hibernation-like state induced by an opioid peptide protects against experimental stroke","volume":"7","author":"CV Borlongan","year":"2009","journal-title":"BMC Biol"},{"key":"ref41","unstructured":"Paxinos G, Watson C (2007) The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition: Academic press."},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1089\/scd.2009.0011","article-title":"Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals","volume":"18","author":"T Yasuhara","year":"2009","journal-title":"Stem Cells Dev"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Dailey T, Eve DJ, Tajiri N, Lau T, Mosley YI, van Loveren H, Sanberg PR, Kaneko Y, Borlongan CV. (2013) Different sources of stem cells for transplantation therapy in stroke. In: <italic>Cell-Based Therapies in Stroke<\/italic>. Jolkkonen J, Walczak P (eds). Springer. 29\u201346.","DOI":"10.1007\/978-3-7091-1175-8_3"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.lfs.2004.09.022","article-title":"Acute functional effects of cyclosporine-A and methylprednisolone treatment in adult rats exposed to transient ischemic stroke","volume":"76","author":"CV Borlongan","year":"2005","journal-title":"Life Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.npep.2011.04.002","article-title":"Cyclosporine-A as a neuroprotective agent against stroke: its translation from laboratory research to clinical application","volume":"45","author":"MM Osman","year":"2011","journal-title":"Neuropeptides"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/exnr.1997.6730","article-title":"Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats","volume":"149","author":"CV Borlongan","year":"1998","journal-title":"Exp Neurol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.6030\/1939-067X-3.1.34","article-title":"Development of an allogeneic adherent stem cell therapy for treatment of ischemic stroke","volume":"3","author":"RW Mays","year":"2010","journal-title":"J Exp Stroke Transl Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3727\/096368911X637380","article-title":"Neuroprotective effect of human placenta-derived cell treatment of stroke in rats","volume":"22","author":"J Chen","year":"2013","journal-title":"Cell Transplant"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1089\/scd.2012.0037","article-title":"Ischemic stroke may activate bone marrow mononuclear cells to enhance recovery after stroke","volume":"21","author":"B Yang","year":"2012","journal-title":"Stem Cells Dev"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1161\/STROKEAHA.108.533091","article-title":"Cell therapy for stroke: remaining issues to address before embarking on clinical trials","volume":"40","author":"CV Borlongan","year":"2009","journal-title":"Stroke"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"S10`7","DOI":"10.1161\/STROKEAHA.112.679605","article-title":"Cell therapies: careful translation from animals to patients","volume":"44","author":"SI Savitz","year":"2013","journal-title":"Stroke"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1747-4949.2012.00840.x","article-title":"Stem cells in stroke treatment: the promise and the challenges","volume":"7","author":"JD Sinden","year":"2012","journal-title":"Int J Stroke"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.expneurol.2005.12.011","article-title":"A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke","volume":"199","author":"K Pollock","year":"2006","journal-title":"Exp Neurol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/STROKEAHA.107.500470","article-title":"Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model","volume":"39","author":"R Guzman","year":"2008","journal-title":"Stroke"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0091408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T05:14:29Z","timestamp":1565241269000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0091408"}},"subtitle":[],"editor":[{"given":"Eva","family":"Mezey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,10]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0091408","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,10]]}}}